- IVI announces its first Chief Science Officer.
- IVI hosts its inaugural Annual Methods Summit, focusing on accelerating the alignment of HTA methods with real-world decision needs.
- Launch of IVI Patient Advisory Council, an advisory body designed to ensure the patient always remains at the forefront of our research.
- Development begins on our third OSVP disease-specific model, which focuses on major depressive disorder (MDD).
